MWNA
ANAB icon

Marshall Wace North America’s AnaptysBio ANAB Stock Holding History

Marshall Wace North America’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-18,591
Closed -$400K – 1483
2020
Q4 		$400K Buy
+18,591
New +$451K ﹤0.01% 1126
2018
Q4 		– Sell
-137,947
Closed -$13.8M – 1459
2018
Q3 		$13.8M Sell
137,947
-2,367
-2% -$196K 0.09% 177
2018
Q2 		$9.97M Sell
140,314
-188,546
-57% -$15.8M 0.06% 336
2018
Q1 		$34.2M Buy
328,860
+141,173
+75% +$15.9M 0.17% 141
2017
Q4 		$18.9M Buy
187,687
+135,014
+256% +$9.94M 0.1% 234
2017
Q3 		$1.84M Sell
52,673
-158,263
-75% -$4.27M 0.01% 816
2017
Q2 		$5.06M Sell
210,936
-36,339
-15% -$913K 0.04% 496
2017
Q1 		$6.92M Buy
+247,275
New +$5.76M 0.05% 330

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace North America's ANAB Position: Q1 2021 in Review

Marshall Wace North America sold out of AnaptysBio (ANAB) in Q1 2021, closing a stake of 18,591 shares — an estimated $400K sold.

Marshall Wace North America first reported a position in ANAB in Q1 2017 and held it in 8 quarters. The position peaked at $34.2M in Q1 2018. 122 funds tracked by Wall St. Rank hold ANAB as of Q1 2021.

  • Marshall Wace North America reported no remaining AnaptysBio position as of Q1 2021 after selling out during the quarter.
  • Marshall Wace North America sold 18,591 AnaptysBio shares in Q1 2021, an estimated $400K.
  • Marshall Wace North America first reported a position in AnaptysBio in Q1 2017 and held it in 8 quarters.
  • Marshall Wace North America's AnaptysBio position peaked at $34.2M in Q1 2018.
  • 122 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.